IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts.
about
Assessing specific oligonucleotides and small molecule antibiotics for the ability to inhibit the CRD-BP-CD44 RNA interaction.Molecular insights into the coding region determinant-binding protein-RNA interaction through site-directed mutagenesis in the heterogeneous nuclear ribonucleoprotein-K-homology domains.Characterizing the Coding Region Determinant-Binding Protein (CRD-BP)-Microphthalmia-associated Transcription Factor (MITF) mRNA interaction.Loss of Stromal IMP1 Promotes a Tumorigenic Microenvironment in the Colon.IMP1 suppresses breast tumor growth and metastasis through the regulation of its target mRNAs.LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer.MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.Comparative transcriptomes of adenocarcinomas and squamous cell carcinomas reveal molecular similarities that span classical anatomic boundariesRegulation of Stem Cell Self-Renewal and Oncogenesis by RNA-Binding Proteins.A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation.Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2.RNA Binding Proteins in Intestinal Epithelial Biology and Colorectal Cancer.The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells.Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer.The Molecular Basis and Therapeutic Potential of Let-7 MicroRNAs against Colorectal Cancer.
P2860
Q31153960-327600D0-648D-4FBA-BC0A-B8312BAE02D9Q34801745-FDE8BDCB-F89C-404B-BCF1-874602D2BEB0Q36275178-FE941E6D-111E-4CE9-BD35-7B6129F777C1Q36279559-CE80C394-C9C2-4AE5-BC3B-9E5764317E24Q37085862-CA86FC09-5A88-4CE9-B010-6A23E1C559BEQ37271808-AC0E2DFF-FC81-4E06-A70D-4C771AA163BBQ37507920-480A67F4-87C5-47DA-AD59-088CD80E5C47Q37731180-6DD00E85-19DA-4C82-AF2E-2920C1E8047DQ38634656-E9876262-2823-4CB8-999B-738E859ADB55Q38852157-EB88E888-F81B-4224-81EA-C644DFD0D186Q41563428-5CC22D03-CA98-4ECC-9594-8FCEFE38DD1AQ42420606-F7239282-0162-44B8-9326-D9583E8268E6Q52600941-EAD1FD20-9FC9-4A61-8645-C084111BC886Q55004493-CDADD25F-0821-45D9-9CE7-4FEC065E8B7CQ55499961-16655ABA-5889-4B8C-936F-E31E5BD977A4Q55717664-220CFBFA-1D12-4F32-8A97-9D9677131D0D
P2860
IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IMP1 promotes tumor growth, di ...... rectal cancer cell xenografts.
@en
IMP1 promotes tumor growth, di ...... rectal cancer cell xenografts.
@nl
type
label
IMP1 promotes tumor growth, di ...... rectal cancer cell xenografts.
@en
IMP1 promotes tumor growth, di ...... rectal cancer cell xenografts.
@nl
prefLabel
IMP1 promotes tumor growth, di ...... rectal cancer cell xenografts.
@en
IMP1 promotes tumor growth, di ...... rectal cancer cell xenografts.
@nl
P2093
P2860
P356
P1433
P1476
IMP1 promotes tumor growth, di ...... rectal cancer cell xenografts.
@en
P2093
Andres J Klein-Szanto
Andrew D Rhim
Anil K Rustgi
Christopher M Hahn
Emma T Lundsmith
Felicite K Noubissi
Kathryn E Hamilton
Prateek S Katti
Sonya R Davey
Vladimir S Spiegelman
P2860
P304
P356
10.1093/CARCIN/BGT217
P407
P577
2013-06-12T00:00:00Z